Pancreatic Cancer Research

ResearcherMayo ClinicActive in the last 2 years

Toshiro Masuda

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-4306-4277; OpenAlex author ID A5018999603, A5038638554. Sources: OpenAlex.

Their work

Papers
7 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
29
Papers, trials and grants by year

2014: 1 paper · 2015: none · 2016: none · 2017: 1 paper · 2018: 1 paper · 2019: 1 paper · 2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: 1 paper · 2025: none · 2026: 1 paper

Papers 7

  1. An 8-Year Survivor after Three-Time Hepatectomies for Metachronous Pancreatic Adenocarcinoma Liver Metastases. Co-author DOI 10.70352/scrj.cr.25-0242↗
  2. Combined Neutrophil-to-Lymphocyte Ratio Score Is Associated With Chemotherapeutic Response and Predicts Prognosis in Patients With Advanced Pancreatic Cancer. First author DOI 10.21873/anticanres.16955↗
  3. Impact of resection margin status on survival in pancreatic cancer patients after neoadjuvant treatment and pancreatoduodenectomy. Co-author DOI 10.1016/j.surg.2019.12.008↗
  4. Conversion surgery for initially unresectable pancreatic ductal adenocarcinoma with synchronous liver metastasis after treatment with FOLFIRINOX. Co-author DOI 10.1007/s12328-019-00965-z↗
  5. A Comprehensive Assessment of Accurate Lymph Node Staging and Preoperative Detection in Resected Pancreatic Cancer. Co-author DOI 10.1007/s11605-017-3607-7↗
  6. Pancreatic Cancer Arising From the Remnant Pancreas: Is It a Local Recurrence or New Primary Lesion? Co-author DOI 10.1097/mpa.0000000000000897↗
  7. Splanchnicectomy for pancreatic cancer pain. Co-author DOI 10.1155/2014/941726↗

Closest collaborators

The 25 strongest of 29 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Masahiko Hirota · 2 shared papers, 2024–2026 · strength 0.50
  2. Hiroki Sugita · 2 shared papers, 2024–2026 · strength 0.50
  3. Hirohisa Okabe · 2 shared papers, 2024–2026 · strength 0.50
  4. Hideo Baba · 4 shared papers, 2017–2024 · strength 0.44
  5. Naoki Umezaki · 1 shared paper, 2026 · strength 0.30
  6. Hidetoshi Nitta · 1 shared paper, 2026 · strength 0.30
  7. Howard A. Reber · 3 shared papers, 2017–2020 · strength 0.24
  8. Timothy R. Donahue · 2 shared papers, 2018–2020 · strength 0.17
  9. Mark D. Girgis MD · 2 shared papers, 2018–2020 · strength 0.17
  10. Tatsuo Hata · 1 shared paper, 2020 · strength 0.09
  11. Shimpei Maeda · 1 shared paper, 2020 · strength 0.09
  12. Sean Patrick Cleary · 1 shared paper, 2020 · strength 0.09
  13. Travis Edward Grotz · 1 shared paper, 2020 · strength 0.09
  14. Alexandra M. Moore · 1 shared paper, 2020 · strength 0.09
  15. Michael L. Kendrick · 1 shared paper, 2020 · strength 0.09
  16. Mark Joseph Truty · 1 shared paper, 2020 · strength 0.09
  17. Michiaki Unno · 1 shared paper, 2020 · strength 0.09
  18. Fuyuhiko Motoi · 1 shared paper, 2020 · strength 0.09
  19. Ozaki Kentaro · 1 shared paper, 2019 · strength 0.09
  20. Hiromitsu Hayashi · 1 shared paper, 2019 · strength 0.09
  21. Hiroshi Takamori · 1 shared paper, 2019 · strength 0.09
  22. Irmina A. Elliott · 1 shared paper, 2018 · strength 0.08
  23. V. Raman Muthusamy · 1 shared paper, 2018 · strength 0.08
  24. Oscar Joe Hines · 1 shared paper, 2018 · strength 0.08
  25. Akira Chikamoto · 1 shared paper, 2017 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.